Unknown PHASE4 INTERVENTIONAL 2-arm NCT03209687

The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles

Human Menopausal Gonadotropin as a Novel Addition to Luteal Phase Support in Down-regulated ICSI Cycles (RCT)

Sponsor: Cairo University

Interventions human menopausal gonadotropin

Updated 11 times since 2017 Last updated: Feb 8, 2023 Started: Jul 6, 2017 Primary completion: Jul 15, 2024 Completion: Aug 15, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03209687, this PHASE4 trial focuses on Infertility and remains ongoing. Sponsored by Cairo University, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Mar 2025 — Present [monthly]

Unknown PHASE4

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Mar 2023 — Jul 2024 [monthly]

Recruiting PHASE4
Apr 2022 — Mar 2023 [monthly]

Recruiting PHASE4

▶ Show 6 earlier versions

Feb 2021 — Apr 2022 [monthly]

Recruiting PHASE4
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE4
Aug 2019 — Jan 2021 [monthly]

Recruiting PHASE4
Aug 2018 — Aug 2019 [monthly]

Recruiting PHASE4
Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE4
Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt